Page last updated: 2024-10-30

losartan and Dermatitis Medicamentosa

losartan has been researched along with Dermatitis Medicamentosa in 3 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marquart-Elbaz, C1
Grosshans, E1
Lipsker, D2
Saraceno, R1
Citarella, L1
Spallone, G1
Chimenti, S1
Haddad, AM1
Scholer, SG1

Other Studies

3 other studies available for losartan and Dermatitis Medicamentosa

ArticleYear
Sartans, angiotensin II receptor antagonists, can induce psoriasis.
    The British journal of dermatology, 2002, Volume: 147, Issue:3

    Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Drug Eruptions; Female; Humans; Los

2002
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy.
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Deri

2008
Possible losartan-induced rash.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Jun-01, Volume: 54, Issue:11

    Topics: Antihypertensive Agents; Biphenyl Compounds; Drug Eruptions; Female; Humans; Imidazoles; Losartan; M

1997